Home / Journals Advances in Biochemistry / Study of Glycemic Biomarkers in Patients of Thyroid Disorders
Study of Glycemic Biomarkers in Patients of Thyroid Disorders
Submission DeadlineDec. 25, 2019

Submission Guidelines: http://www.sciencepublishinggroup.com/home/submission

Lead Guest Editor
Varsha Chowdhry
J.Ln Medical College Ajmer ( Rajasthan University Of Health Sciences), Jaipur, India
Guest Editors
  • Balram Chowdhry
    Gheesibai Memorial Mittal Hospital and Research Centre, Ajmer, Rajasthan, India
  • Varsha Chowdhry
    J.Ln Medical College Ajmer ( Rajasthan University Of Health Sciences), Jaipur, India
Introduction
Thyroid disorders are commonest disorders worldwide. Various glycated proteins can be used as glycaemic biomarkers to determine the degree of glycaemia in thyroid patients. They are useful glycaemic biomarkers to monitor the short-term glycaemic changes in the patients with thyroid disorders and have a role in conjugation with glycated haemoglobin. Serum fructosamine and glycated albumin correlate well with serum glucose. So, the present study was conducted to evaluate the changes and compare the levels of various glycaemic biomarkers like serum fructosamine, glycated albumin, glycated haemoglobin in overt hypothyroid, subclinical hypothyroid, hyperthyroid patients in comparison to controls and the levels of total protein and serum albumin was estimated in thyroid disorder patients. The present descriptive comparative study has been conducted on 300 subjects of either sex of various age groups. Study included diagnosed thyroid disorder patients (200) attending medical OPD, patients admitted in medical and surgical wards and patients coming in Radioimmunoassay (RIA) laboratory, Biochemistry Department, JLN Medical College and Hospital, Ajmer. The results of patients were compared with the hundred healthy subjects of either sex of similar age group. The indices included: - Serum fructosamine assayed by Nitroblue Tetrazolium Kinetic Method, Serum Glycated Albumin by Enzyme-Linked Immunosorbent Assay, Total protein by Biuret method, Fasting blood glucose by GOD-POD method and HbA1c by Ion-Exchange Resin Method. RESULTS The mean serum fructosamine were higher in overt hypothyroid and subclinical hypothyroid patients in comparison to healthy control, vice-a-versa was found in hyperthyroid patients (p < 0.001) (HS). Mean glycated albumin levels were higher in overt hypothyroid patients (p < 0.005) and subclinical hypothyroid patients in comparison to healthy control, vice-a-versa was found in hyperthyroid patients. Total protein levels were higher in overt hypothyroid and subclinical hypothyroid patients. Serum albumin levels were higher in overt hypothyroid patients in comparison to hyperthyroid and healthy control, which was statistically significant. CONCLUSION The present study concluded that serum fructosamine and serum glycated albumin are better short-term glycaemic markers than glycated haemoglobin and fasting blood glucose level in thyroid disorder patients.
Aims and Scope:
  1. Present Study Is On Serum Fructosamine
  2. Glycated Albumin
  3. Other Glycemic Markers
  4. Hba1c
  5. Throid Disorders
  6. Total Protein And Albumin
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=110).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186